| Noopept Basic information | |
| Product Name: | Noopept |
| Synonyms: | ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate；N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester;Ethyl 1-(phenylacetyl)-L-prolylglycinate;noopept powder;Nootropic GVS-111;(S)-ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxaMido)acetate;SGS 111 |
| CAS: | 157115-85-0 |
| MF: | C17H22N2O4 |
| 318.37 | 318.37 |
| EINECS: | 1592732-453-0 |
| Product Categories: | Nutrients; Compound; Inhibitor. Nutritional raw materials; Food additives; Membrane transport/ion channel; Pharmaceutical intermediates. |
| Mol File: | 157115-85-0.mol |
| Introduction | N-(1-(phenyl acetyl) -L-prolyl) glycine ethyl ester under the trade name NOOPEPT, as a treatment for obesity, alcohol-dependent degeneration or toxic damage |
| Noopept Chemical Properties | |
| Melting point | 94.0 to 98.0 °C |
| Boiling point | 547.3±50.0 °C(Predicted) |
| density | 1.202±0.06 g/cm3(Predicted) |
| pKa | 13.41±0.20(Predicted) |
| storage temp. | -20°C |
| optical activity | [α]/D -115 to -125°, c = 0.5 in chloroform-d |
| form | powder |
| color | white to beige |